Product Information
GLYBURIDE 5 MG TABLET is a generic product labeled by Modavar Pharmaceuticals LLC, priced at $0.0643 per EA under NDC 72241004010. Its NADAC has been published 223 times since Jun 29, 2022.
FDA first approved this application on Jan 4, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Modavar Pharmaceuticals LLCNDC
72241004010
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GLYBURIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203379FDA Approved
1/4/2019
TE Code
AB1
On Market Since
10/5/2021
Pharmacological Classes
Price Statistics
The NADAC for GLYBURIDE 5 MG TABLET has been published 223 times since Jun 29, 2022, and over the history we have for it it has declined 28.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0643 per EA |
|---|---|
| All-time high | $0.1011 (Mar 15, 2023) |
| All-time low | $0.0502 (May 22, 2024) |
| 52-week high | $0.0655 |
| 52-week low | $0.0528 |
| Median price | $0.0606 |
| Average price | $0.0651 |
| Largest weekly change | +40.3% (Feb 22, 2023) |
| Weeks tracked | 223 |
| Tracking since | Jun 29, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Modavar Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Glyburide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonylurea class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLYBURIDE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLYBURIDE 5 MG TABLET, manufactured by Modavar Pharmaceuticals LLC, is $0.0643 per EA (NDC 72241004010), effective Sep 30, 2026.
How has the price of GLYBURIDE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLYBURIDE 5 MG TABLET has declined 28.2%. It has been tracked across 223 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for GLYBURIDE 5 MG TABLET?
Since Jun 29, 2022, the NADAC for GLYBURIDE 5 MG TABLET has ranged from a low of $0.0502 (May 22, 2024) to a high of $0.1011 (Mar 15, 2023), with a median of $0.0606 per EA.
Are there cheaper alternatives to GLYBURIDE 5 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GLYBURIDE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GLYBURIDE 5 MG TABLET?
GLYBURIDE 5 MG TABLET (NDC 72241004010) is labeled by Modavar Pharmaceuticals LLC, and CMS classifies it as a generic product.